4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001209191-17-031962
CIK 0001175505operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:28 PM ET
Size
5.4 KB
Accession
0001209191-17-031962
Insider Transaction Report
Form 4
Jensen Peder
Director
Transactions
- Award
Stock Option (right to buy)
2017-05-10+10,000→ 10,000 totalExercise: $29.80Exp: 2027-05-09→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) May 10, 2018 or (ii) the day before the 2018 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:28 PM ET
- Size
- 5.4 KB